Financials SenesTech, Inc.

Equities

SNES

US81720R5054

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:01 2024-04-26 pm EDT 5-day change 1st Jan Change
0.7285 USD -2.84% Intraday chart for SenesTech, Inc. +1.48% -42.64%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 15.56 7.761 11.95 2.108 6.082 3.748 - -
Enterprise Value (EV) 1 15.56 7.761 11.95 2.108 6.082 3.748 3.748 3.748
P/E ratio -1.43 x -0.62 x -1.32 x -0.2 x -0.11 x -1.1 x -1.66 x -1.87 x
Yield - - - - - - - -
Capitalization / Revenue 109 x 27.5 x 19.9 x - 5.1 x 1.66 x 0.83 x 0.46 x
EV / Revenue 109 x 27.5 x 19.9 x - 5.1 x 1.66 x 0.83 x 0.46 x
EV / EBITDA - -1.13 x -1.52 x - -0.88 x -0.78 x -0.84 x -1.16 x
EV / FCF - -1.07 x - - - -0.55 x -0.67 x -0.92 x
FCF Yield - -93.1% - - - -182% -150% -109%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 5.89 18.7 50.9 56.8 4,789 5,145 - -
Reference price 2 2,640 414.0 234.9 37.08 1.270 0.7285 0.7285 0.7285
Announcement Date 3/16/20 3/25/21 3/29/22 3/16/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 0.143 0.282 0.6 - 1.193 2.254 4.508 8.114
EBITDA 1 - -6.881 -7.841 - -6.922 -4.824 -4.468 -3.244
EBIT 1 -10.29 -7.933 -8.934 - -7.732 -6.006 -5.698 -4.531
Operating Margin -7,193.71% -2,813.12% -1,489% - -648.11% -266.46% -126.4% -55.84%
Earnings before Tax (EBT) 1 -10.02 -7.937 -8.268 - -7.71 -6.589 -6.678 -5.93
Net income 1 -10.03 -8.373 -8.268 -9.695 -7.71 -6.589 -6.678 -5.93
Net margin -7,013.29% -2,969.15% -1,378% - -646.27% -292.32% -148.14% -73.08%
EPS 2 -1,846 -667.2 -177.6 -186.0 -11.51 -0.6600 -0.4400 -0.3900
Free Cash Flow 1 - -7.222 - - - -6.835 -5.612 -4.082
FCF margin - -2,560.99% - - - -303.24% -124.49% -50.31%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/16/20 3/25/21 3/29/22 3/16/23 2/21/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.183 0.169 0.195 0.277 0.25 0.233 0.305 0.36 0.295 0.429 0.485 0.582 0.757
EBITDA 1 -1.961 -2.165 -2.043 -2.277 -2.501 -1.843 -1.678 -1.746 -1.617 -1.397 -1.303 -1.158 -0.966
EBIT 1 -2.253 -2.493 -2.333 -2.572 -2.619 -2.045 -2 -1.951 -1.736 -1.683 -1.596 -1.458 -1.27
Operating Margin -1,231.15% -1,475.15% -1,196.41% -928.52% -1,047.6% -877.68% -655.74% -541.94% -588.47% -392.31% -329.07% -250.52% -167.77%
Earnings before Tax (EBT) 1 -2.253 -2.494 -2.332 -2.569 -2.646 -2.037 -1.993 -1.947 -1.733 -1.743 -1.741 -1.632 -1.473
Net income 1 -2.253 -2.494 -2.332 -2.569 -2.646 -2.037 -1.993 -1.947 -1.733 -1.743 -1.741 -1.632 -1.473
Net margin -1,231.15% -1,475.74% -1,195.9% -927.44% -1,058.4% -874.25% -653.44% -540.83% -587.46% -406.29% -358.97% -280.41% -194.58%
EPS 2 -43.20 -50.40 -45.60 -50.40 -52.80 -15.84 -8.400 -5.640 -9.540 -0.3400 -0.1100 -0.1100 -0.1000
Dividend per Share - - - - - - - - - - - - -
Announcement Date 11/10/21 3/29/22 5/12/22 8/11/22 11/14/22 5/11/23 8/10/23 11/9/23 2/21/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -7.22 - - - -6.84 -5.61 -4.08
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - 0.11 - - - - - -
Capex / Sales - 40.43% - - - - - -
Announcement Date 3/16/20 3/25/21 3/29/22 3/16/23 2/21/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.7285 USD
Average target price
3.5 USD
Spread / Average Target
+380.44%
Consensus
  1. Stock Market
  2. Equities
  3. SNES Stock
  4. Financials SenesTech, Inc.